Stroke drug developer Argenica Therapeutics is planning a second trial to test its novel candidate, in a sector that has few effective therapies.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
The extractor well delivered flow rates of more than 5L/s during pump testing, which is well above typical ISR rates of 0.5 to 3L/s.
Retired for decades but still going strong, octogenarian property developer Alex Brinkmeyer reckons he’s got another 15 years in him to unlock more homes.
St George Mining has recorded more shallow, broad, high-grade rare earths and niobium intercepts.
